Original Article

Early diagnosis, treatment and follow-up of 6 children with autoinflammatory diseases caused by NLRP3 gene variation

  • Shiyu HUANG ,
  • Lijuan LUO ,
  • Jing WANG ,
  • Xia CHEN ,
  • Qing CAO
Expand
  • Department of Infectious Disease, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China

Received date: 2024-01-10

  Online published: 2024-07-08

Abstract

Objective To analyze the clinical features of children with autoinflammatory disease caused by NLRP3 gene variation, and to provide basis for diagnosis and treatment of such children. Methods A retrospective study was conducted on 6 patients diagnosed with autoinflammatory disease caused by NLRP3 gene variation from February 2017 to March 2023. Results A total of 6 children (3 boys and 3 girls) were included. All of the patients developed symptoms in early childhood, with recurrent fever in 5 cases and rash in 6 cases. Before diagnosis, the patients were misdiagnosed as urticaria or atopic dermatitis. One case was misdiagnosed as juvenile idiopathic arthritis due to joint swelling and pain. Four patients were misdiagnosed as suppurative meningitis by lumbar puncture examination and 2 had hearing impairment. One case had obvious multi-organ involvement. Leukocytosis was observed in all 6 cases. C-reactive protein was increased in 5 cases, erythrocyte sedimentation rate was increased in 4 cases, serum amyloid A (SAA) was increased in 4 cases, interleukin-6 (IL-6) was increased in 4 cases, and interleukin-1β (IL-1β) was increased in 2 cases. Five patients had anemia. Four patients were treated with canakinumab by injection every 8 weeks. The patients were followed up for up to 3 years and were generally in good condition. Conclusions NLRP3 gene variations can lead to atypical clinical manifestations of autoinflammatory diseases. Prompt diagnosis and early treatment with IL-1β antagonists like canakinumab supplementation have shown good efficacy in significantly improving clinical symptoms.

Cite this article

Shiyu HUANG , Lijuan LUO , Jing WANG , Xia CHEN , Qing CAO . Early diagnosis, treatment and follow-up of 6 children with autoinflammatory diseases caused by NLRP3 gene variation[J]. Journal of Clinical Pediatrics, 2024 , 42(7) : 643 -647 . DOI: 10.12372/jcp.2024.24e0039

References

[1] Broderick L. Hereditary autoinflammatory disorders: recognition and treatment[J]. Immunol Allergy Clin North Am, 2019, 39(1): 13-29.
[2] Krainer J, Siebenhandl S, Weinh?usel A. Systemic autoinflammatory diseases[J]. J Autoimmun, 2020, 109: 102421.
[3] Aksentijevich I, Putnam CD, Remmers EF, et al. The clinical continuum of cryopyrinopathies: novel CIAS1 mutations in North American patients and a new cryopyrin model[J]. Arthritis Rheum, 2007, 56(4): 1273-1285.
[4] Malcova H, Strizova Z, Milota T, et al. IL-1 Inhibitors in the treatment of monogenic periodic fever syndromes: from the past to the future perspectives[J]. Front Immunol, 2021, 11: 619257.
[5] Welzel T, Kuemmerle-Deschner JB. Diagnosis and management of the cryopyrin-associated periodic syndromes (CAPS): what do we know today?[J]. J Clin Med, 2021, 10(1): 128.
[6] Kapur S, Bonk ME. Rilonacept (arcalyst), an interleukin-1 trap for the treatment of cryopyrin-associated periodic syndromes[J]. P T, 2009, 34(3): 138-141.
[7] Feldmann J, Prieur AM, Quartier P, et al. Chronic infantile neurological cutaneous and articular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonuclear cells and chondrocytes[J]. Am J Hum Genet, 2002, 71(1): 198-203.
[8] Aksentijevich I, Nowak M, Mallah M, et al. De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases[J]. Arthritis Rheum, 2002, 46(12): 3340-3348.
[9] 张俊梅, 李彩凤, 檀晓华, 等. 慢性婴儿神经皮肤关节综合征十例基因变异临床表型及治疗随访分析[J]. 中华风湿病学杂志, 2019, 23(8): 536-539.
[10] Shen M, Qing Y, Shi X, et al. Recommendations of diagnosis of autoinflammatory diseases in China[J]. Zhonghua Nei Ke Za Zhi, 2021, 60(12): 1129-1138.
[11] 中华医学会儿科学分会风湿病学组, 中国医师协会风湿免疫科医师分会儿科学组, 海峡两岸医药卫生交流协会风湿免疫病学专业委员会儿童学组, 等. 儿童自身炎症性疾病诊断与治疗专家共识[J]. 中华实用儿科临床杂志, 2022, 37(3): 161-172.
[12] Turunen JA, Wedenoja J, Repo P, et al. Keratoendotheliitis fugax hereditaria: a novel cryopyrin-associated periodic syndrome caused by a mutation in the nucleotide-binding domain, leucine-rich repeat family, pyrin domain-containing 3 (NLRP3) gene[J]. Am J Ophthalmol, 2018, 188: 41-50.
[13] Ducharme-BéNard S, Roberge G, Chapdelaine H. A unique presentation of NLRP3-associated autoinflammatory disease: case report[J]. BMC Rheumatology, 2022, 6(1): 91.
[14] Papa R, Doglio M, Lachmann HJ, et al. A web-based collection of genotype-phenotype associations in hereditary recurrent fevers from the Eurofever registry[J]. Orphanet J Rare Dis, 2017, 12(1): 167.
[15] Dalgic B, Egritas O, Sari S, et al. A variant Muckle-Wells syndrome with a novel mutation in CIAS1 gene responding to anakinra[J]. Pediatr Nephrol, 2007, 22(9):1391-1394.
[16] Samson JM, Ravindran Menon D, Vaddi PK, et al. Computational modeling of NLRP3 identifies enhanced ATP binding and multimerization in cryopyrin-associated periodic syndromes[J]. Front Immunol, 2020, 11: 584364.
[17] 马明圣, 王薇, 周煜, 等. 炎症小体病35例临床特征分析[J]. 中华儿科杂志, 2022, 60(2): 114-118.
[18] Dinarello CA. Interleukin-1 in the pathogenesis and treatment of inflammatory diseases[J]. Blood, 2011, 117(14): 3720-3732.
[19] Kuemmerle-Deschner JB. CAPS — pathogenesis, presentation and treatment of an autoinflammatory disease[J]. Semin Immunopathol, 2015, 37(4): 377-385.
[20] Hashkes PJ, Lovell DJ. Recognition of infantile-onset multisystem inflammatory disease as a unique entity[J]. J Pediatr, 1997, 130(4): 513-515.
[21] Li C, Tan X, Zhang J, et al. Gene mutations and clinical phenotypes in 15 Chinese children with cryopyrin-associated periodic syndrome (CAPS)[J]. Sci China Life Sci, 2017, 60(12): 1436-1444.
[22] Zhou Y, Wang W, Zhong L, et al. Clinical and genetic spectrum of 14 cases of NLRP3-associated autoinflammatory disease (NLRP3-AID) in China and a review of the literature[J]. Orphanet J Rare Dis, 2022, 17(1): 214.
Outlines

/